Why the study?
The effect of different levels of leisure-time moderate-to-vigorous physical activity against cardiocerebrovascular and all-cause mortality in hypertension was unclear.
Does moderate-to-vigorous physical activity reduce cardiocerebrovascular and all-cause mortality in adult patients with hypertension?
Population
NHANES participants with hypertension from 1999 to 2006
Comparison
Inactive vs low-active vs high-active MV-PA
Design
Cohort study
Follow-up
Median 10.93-year
Key result
High levels of moderate-to-vigorous physical activity (≥7.5 MET-h/week) significantly reduced the risk of cardiocerebrovascular mortality by 44% (HR 0.56) compared to physical inactivity in patients with hypertension.
Authors
Loading...
May support 7.5–15 MET-h/wk MV-PA for lowest mortality in hypertension; leaves open causality and optimal dosing in trials.
Cohort (n=4,917)
Does moderate-to-vigorous physical activity reduce cardiocerebrovascular and all-cause mortality in adult patients with hypertension?
Hazard Ratio: 0.56 (95% CI 0.41–0.77)
Absolute Event Rate: 4.95% vs 13.85%
p-value: p=<0.001
In patients with hypertension, engaging in moderate-to-vigorous physical activity of 7.5 to < 15 MET-h/week is associated with the lowest risks of cardiocerebrovascular and all-cause mortality.
Xu et al. (2022) conducted a cohort in Hypertension (n=4,917). High moderate-to-vigorous physical activity (≥7.5 MET-h/week) vs. Physical inactivity (0 MET-h/week) was evaluated on Cardiocerebrovascular mortality (HR 0.56, 95% CI 0.41-0.77, p=<0.001). High levels of moderate-to-vigorous physical activity (≥7.5 MET-h/week) significantly reduced the risk of cardiocerebrovascular mortality by 44% (HR 0.56) compared to physical inactivity in patients with hypertension.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: